about
Endofin recruits TOM1 to endosomesThe adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factorsParticipation of Tom1L1 in EGF-stimulated endocytosis of EGF receptorAnalysis of oncogenic signaling induced by tyrosine kinases in tumors by SILAC-based quantitative proteomic approachTOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion.Structure of the GAT domain of human GGA1: A syntaxin amino-terminal domain fold in an endosomal trafficking adaptorNovel proteins linking the actin cytoskeleton to the endocytic machinery in Saccharomyces cerevisiaeSignaling initiated by overexpression of the fibroblast growth factor receptor-1 investigated by mass spectrometryTollip and Tom1 form a complex and recruit ubiquitin-conjugated proteins onto early endosomesTemporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomicsActivation of the lutropin/choriogonadotropin receptor in MA-10 cells stimulates tyrosine kinase cascades that activate ras and the extracellular signal regulated kinases (ERK1/2).TOM1L1 is a Lyn substrate involved in FcepsilonRI signaling in mast cells.TOM1L is involved in a novel signaling pathway important for the IL-2 production in Jurkat T cells stimulated by CD3/CD28 co-ligation.Srcasm modulates EGF and Src-kinase signaling in keratinocytes.Decreased Srcasm expression in hyperproliferative cutaneous lesionsFrom keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.A Central Nervous System-Dependent Intron-Embedded Gene Encodes a Novel Murine Fyn Binding Protein.Analysis of SRC oncogenic signaling in colorectal cancer by stable isotope labeling with heavy amino acids in mouse xenograftsMultiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition.Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.Vesicular trafficking regulators are new players in breast cancer progression: Role of TOM1L1 in ERBB2-dependent invasion.The Tom1L1-clathrin heavy chain complex regulates membrane partitioning of the tyrosine kinase Src required for mitogenic and transforming activities.Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.Activation of Src-family tyrosine kinases in hyperproliferative epidermal disorders.Extracellular domain splice variants of a transforming protein tyrosine phosphatase alpha mutant differentially activate Src-kinase dependent focus formation.MLL-mediated transcriptional gene regulation investigated by gene expression profiling.Oligonucleotide microarray analysis of ameloblastoma compared with dentigerous cyst.Srcasm overexpression in psoriasis-insights into pathogenesis.
P2860
Q24299623-112FA48B-EB11-46F5-9440-B1540BDE68B0Q24304594-F2C6DC17-5749-4F5C-A78F-0C9A9C68A450Q24320039-96BC9F79-97CF-4001-807D-F71EE170187CQ26852884-0DECEF03-36CB-4B78-A32B-9889FCD72C2EQ27330524-913EDEE0-D958-4AEF-ABD1-5FD77EE69062Q27640868-A2E22134-F37F-4C67-A75E-4938DFF6C339Q27936195-EC10FA0D-A73C-4AAB-A196-E2134264B3A1Q28211506-0E12573D-C77C-4F4C-820B-C2E58DE27AACQ28253040-14C3F0B3-1899-4A27-8462-66C80470D280Q28277407-BA857AD9-1D43-4DB7-ADB0-5C622E25C7FFQ30446457-59C722BD-02EB-4365-9F3E-BBCE0BF932A0Q33304751-ED9D171D-3CD3-449A-8FB3-D4ED418666CCQ33674682-B3A0053E-14A7-4A1B-AD7D-1D6AEE7C4B12Q34373519-AE0CD69A-74CB-4571-8352-D40E552972B0Q34997036-DFBDC9CC-46AC-4D1C-B56D-0BD769CCA516Q35698913-AEA9B065-643D-4C52-BAFC-FB8CCEB964E2Q35930905-244BFB44-50DA-4566-9A87-F1D956DC8AE4Q36455713-B56AC4A8-FDC1-4095-99F3-5657ED5E5EA4Q37415946-FBFFBEF8-A141-42C2-93B5-62E76F17C955Q37480072-840B8872-FF29-478C-B4E9-58765FB3F453Q40572097-6C37FF69-45B5-48E2-B10C-8C01C8DBDC15Q41824025-4ABE7161-335D-430D-A7CA-5FE683BC3A81Q41944335-451FDF60-0E2A-44EB-88C9-CBF791FACF85Q42737351-29864170-1B85-46CC-93B7-BA19CA9FA82EQ42832151-EB5FAA28-C59B-4282-8809-6AC2A72E3F73Q52550858-62052E09-D5C4-46E0-A5B3-15711298FFD0Q53347061-D457F82C-6568-4EED-B511-FFA275407956Q54560906-F307F8EF-42A9-4018-B640-9B791134C8B3
P2860
description
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2002
@ast
im Januar 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/01/25)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/01/25)
@nl
наукова стаття, опублікована в січні 2002
@uk
name
'Srcasm: a novel Src activating and signaling molecule
@ast
'Srcasm: a novel Src activating and signaling molecule
@en
'Srcasm: a novel Src activating and signaling molecule
@nl
type
label
'Srcasm: a novel Src activating and signaling molecule
@ast
'Srcasm: a novel Src activating and signaling molecule
@en
'Srcasm: a novel Src activating and signaling molecule
@nl
prefLabel
'Srcasm: a novel Src activating and signaling molecule
@ast
'Srcasm: a novel Src activating and signaling molecule
@en
'Srcasm: a novel Src activating and signaling molecule
@nl
P2093
P2860
P921
P356
P1476
'Srcasm: a novel Src activating and signaling molecule
@en
P2093
G. Paolo Dotto
John T. Seykora
Lijuan Mei
Paul L. Stein
P2860
P304
P356
10.1074/JBC.M106813200
P407
P577
2002-01-25T00:00:00Z